Latest Content

AI Navigation May Help Patients Schedule Missed Colonoscopies

May 23rd 2024, 10:00pm

By Darlene Dobkowski, MA

Article

An artificial intelligence-based navigation tool may be used to call patients who previously missed their colonoscopy appointment with the goal that they will reschedule and attend the new appointment.

Most Patients Attempting Pregnancy After Breast Cancer Succeed

May 23rd 2024, 9:00pm

By Brielle Benyon

Article

In a group of breast cancer survivors, 73% who attempted pregnancy were successful, though there were certain characteristics associated with an increased chance of getting pregnant.

Knowing Benefits, Risks of Bladder-Conserving Therapies in Bladder Cancer

May 23rd 2024, 7:00pm

By Ashley Chan

Article

Bladder-conserving treatment may be beneficial for certain patients with non-muscle-invasive bladder cancer, and may not be for those with high-risk disease.

My Immunotherapy Journey During Lung Cancer

May 23rd 2024, 5:00pm

By Sue McCarthy

Article

When I received my diagnosis of lung cancer, I didn't want to have chemotherapy, but the doctor knew best.

Lymph Node Radiation Reduced Death in Young Patients with Prostate Cancer

May 23rd 2024, 3:00pm

By Alex Biese

Article

Whole-pelvic radiation conferred a 67% lower risk of all-cause mortality among patients younger than 65 with unfavorable-risk prostate cancer.

The Unexpected Joy of Cancer

May 23rd 2024, 1:00pm

By Joseph Ferrier

Article

My colon cancer diagnosis significantly dwarfed all my other problems.

MRD Status May Help Personalize Myeloma Treatment

May 22nd 2024, 9:00pm

By Ashley Chan

Article

Using tests to identify minimal residual disease may help determine how much treatment patients with multiple myeloma require.

Zanubrutinib-Based Treatment Clinical Trial Updates

May 22nd 2024, 8:22pm

By Yuliya P.L Linhares, MD

Video

Expert perspectives on the SEQUOIA study, which is investigating zanubrutinib in patients with chronic lymphocytic leukemia.

Venetoclax-Based Treatment Clinical Trial Updates

May 22nd 2024, 8:18pm

By Yuliya P.L Linhares, MD

Video

Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.

FDA to Review Inavolisib Combo for HR-Positive, HER2-Negative Breast Cancer

May 22nd 2024, 7:00pm

By Brielle Benyon

Article

The Food and Drug Administration granted a breakthrough therapy designation to inavolisib plus Ibrance and fulvestrant for HR-positive, HER2-negative locally advanced or metastatic breast cancer.

My Sister’s Cancer Anniversaries Are Days of Gratitude

May 22nd 2024, 5:00pm

By Kim Johnson

Article

My sister and I have learned to focus on the present day after a rollercoaster ride of remission, a cure and recurrence of stage 4 Hodgkin lymphoma.

Chemo for Breast Cancer May Lead to Declined Physical Function

May 22nd 2024, 3:00pm

By Ashley Chan

Article

Aerobic and strength training exercises may help preserve physical functioning in older adults with early-stage breast cancer who received chemotherapy.

A Poem About Cancer and Weeds

May 22nd 2024, 1:00pm

By Shoshana D. Kerewsky

Article

With my breast cancer experience, there's always a juxtaposition between the fear of mortality and the hope of living.

Onivyde May Have Similar Survival Outcomes as Chemo in Small Cell Lung Cancer

May 21st 2024, 9:00pm

By Ashley Chan

Article

Onivyde did not outperform chemotherapy in improving outcomes for patients with relapsed small cell lung cancer, despite having better response rates.

Aricept Does Not Improve Chemo Brain, But Other Interventions Might

May 21st 2024, 7:00pm

By Brielle Benyon

Article

An Alzheimer’s drug did not have an effect on cognitive function in breast cancer survivors. However, one researcher noted reasons why there is still hope.